These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15354678)

  • 1. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma.
    Skrepnek GH; Skrepnek SV
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S129-38. PubMed ID: 15354678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and global impact of chronic obstructive pulmonary disease.
    Mannino DM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
    Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
    COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease: diagnosis and management.
    Downs CA; Appel SJ
    J Am Acad Nurse Pract; 2007 Mar; 19(3):126-32. PubMed ID: 17341279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease: definition and epidemiology.
    Mannino DM
    Respir Care; 2003 Dec; 48(12):1185-91; discussion 1191-3. PubMed ID: 14651759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma.
    Skrepnek GH; Skrepnek SV
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S139-52. PubMed ID: 15354679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease.
    Pietila MP; Thomas CF
    Semin Respir Infect; 2003 Mar; 18(1):9-16. PubMed ID: 12652449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational health and general practice: from opportunities lost to opportunities capitalised?
    van Weel C; Orbon K; van der Gulden J; Buijs P; Folgering H; Thoonen B; Schermer T
    Med Lav; 2006; 97(2):288-94. PubMed ID: 17017361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease: the disease and its burden to society.
    Halpin DM; Miravitlles M
    Proc Am Thorac Soc; 2006 Sep; 3(7):619-23. PubMed ID: 16963544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of chronic obstructive pulmonary disease].
    Scognamiglio A; Matteelli G; Pistelli F; Baldacci S; Carrozzi L; Viegi G
    Ann Ist Super Sanita; 2003; 39(4):467-84. PubMed ID: 15098569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating chronic obstructive pulmonary disease from asthma.
    Kuebler KK; Buchsel PC; Balkstra CR
    J Am Acad Nurse Pract; 2008 Sep; 20(9):445-54. PubMed ID: 18786021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of asthma in children: a European perspective.
    Sennhauser FH; Braun-Fahrländer C; Wildhaber JH
    Paediatr Respir Rev; 2005 Mar; 6(1):2-7. PubMed ID: 15698807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of occupational asthma and chronic obstructive pulmonary disease].
    Pałczyński C
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():45-7. PubMed ID: 15524015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
    Simoens S; Decramer M; Laekeman G
    Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of chronic obstructive pulmonary disease and its effects on managed care.
    Mapel D; Chen JC; George D; Halbert RJ
    Manag Care Interface; 2004 Apr; 17(4):61-6. PubMed ID: 15108761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma and COPD: definitions, epidemiology, and treatment guidelines.
    Berger WE; Cline DC
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):2-8. PubMed ID: 19667710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands.
    Rutten van-Mölken MP; Feenstra TL
    Pharmacoeconomics; 2001; 19 Suppl 2():1-6. PubMed ID: 11700783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem.
    Sethi S; File TM
    Curr Med Res Opin; 2004 Oct; 20(10):1511-21. PubMed ID: 15462685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.